Cargando…

CT-Guided Coeliac Plexus Neurolysis in Patients with Intra-Abdominal Malignancy: A Retrospective Evaluation of 52 Palliative In-Patients

INTRODUCTION: Prevalence rates of chronic abdominal pain (CAP) and breakthrough cancer pain (BTcP) are high in patients with intra-abdominal malignancies. As part of a multimodal approach, CT-guided coeliac plexus blockade (CPB) and CT-guided coeliac plexus neurolysis (CPN) are commonly used pain ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Neuwersch-Sommeregger, Stefan, Köstenberger, Markus, Stettner, Haro, Pipam, Wofgang, Breschan, Christian, Feigl, Georg, Likar, Rudolf, Egger, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586091/
https://www.ncbi.nlm.nih.gov/pubmed/34546553
http://dx.doi.org/10.1007/s40122-021-00317-1
_version_ 1784597824337346560
author Neuwersch-Sommeregger, Stefan
Köstenberger, Markus
Stettner, Haro
Pipam, Wofgang
Breschan, Christian
Feigl, Georg
Likar, Rudolf
Egger, Markus
author_facet Neuwersch-Sommeregger, Stefan
Köstenberger, Markus
Stettner, Haro
Pipam, Wofgang
Breschan, Christian
Feigl, Georg
Likar, Rudolf
Egger, Markus
author_sort Neuwersch-Sommeregger, Stefan
collection PubMed
description INTRODUCTION: Prevalence rates of chronic abdominal pain (CAP) and breakthrough cancer pain (BTcP) are high in patients with intra-abdominal malignancies. As part of a multimodal approach, CT-guided coeliac plexus blockade (CPB) and CT-guided coeliac plexus neurolysis (CPN) are commonly used pain management strategies. The aim of this study was to evaluate pain outcomes among patients with intra-abdominal malignancies who underwent CPB and/or CPN. METHODS: Patients with intra-abdominal malignancies who underwent CPB and/or CPN for pain control at the general hospital Klagenfurt am Wörthersee from 2010 to 2019 were enrolled. RESULTS: A total of 84 procedures (24 CPB and 60 CPN) were performed on 52 patients; 62% of these patients had pancreatic cancer. CPN led to significant pain reduction and decreased BTcP intensity. Patients receiving repeated CPN showed higher individual pain reduction. Higher pre-procedural pain intensity was correlated with higher pain reduction. No difference in pain reduction in patients receiving a diagnostic CPB prior to CPN compared to patients without a diagnostic CPB was found. Higher pain reduction after CPN led to longer-lasting pain relief. The time frame from diagnosis to CPN was 472 (± 416) days. Patients experienced a mean duration of pain prior to CPN of 330 (± 53) days. The time frame from diagnosis to CPN was shorter in patients with pancreatic cancer compared to other intra-abdominal malignancies. In 58% of patients pain medication was stable or was reduced after CPN; 16% of patients complained about pain during the procedure; no major complications occurred. There was no correlation between median survival after CPN and pain outcomes. CONCLUSIONS: In patients with intra-abdominal malignancy-related CAP, CPN is a safe and effective procedure which can provide long-lasting significant relief of background pain and BTcP. As part of a multimodal approach, CPN should be considered as an earlier option for pain management in these patients.
format Online
Article
Text
id pubmed-8586091
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-85860912021-11-15 CT-Guided Coeliac Plexus Neurolysis in Patients with Intra-Abdominal Malignancy: A Retrospective Evaluation of 52 Palliative In-Patients Neuwersch-Sommeregger, Stefan Köstenberger, Markus Stettner, Haro Pipam, Wofgang Breschan, Christian Feigl, Georg Likar, Rudolf Egger, Markus Pain Ther Original Research INTRODUCTION: Prevalence rates of chronic abdominal pain (CAP) and breakthrough cancer pain (BTcP) are high in patients with intra-abdominal malignancies. As part of a multimodal approach, CT-guided coeliac plexus blockade (CPB) and CT-guided coeliac plexus neurolysis (CPN) are commonly used pain management strategies. The aim of this study was to evaluate pain outcomes among patients with intra-abdominal malignancies who underwent CPB and/or CPN. METHODS: Patients with intra-abdominal malignancies who underwent CPB and/or CPN for pain control at the general hospital Klagenfurt am Wörthersee from 2010 to 2019 were enrolled. RESULTS: A total of 84 procedures (24 CPB and 60 CPN) were performed on 52 patients; 62% of these patients had pancreatic cancer. CPN led to significant pain reduction and decreased BTcP intensity. Patients receiving repeated CPN showed higher individual pain reduction. Higher pre-procedural pain intensity was correlated with higher pain reduction. No difference in pain reduction in patients receiving a diagnostic CPB prior to CPN compared to patients without a diagnostic CPB was found. Higher pain reduction after CPN led to longer-lasting pain relief. The time frame from diagnosis to CPN was 472 (± 416) days. Patients experienced a mean duration of pain prior to CPN of 330 (± 53) days. The time frame from diagnosis to CPN was shorter in patients with pancreatic cancer compared to other intra-abdominal malignancies. In 58% of patients pain medication was stable or was reduced after CPN; 16% of patients complained about pain during the procedure; no major complications occurred. There was no correlation between median survival after CPN and pain outcomes. CONCLUSIONS: In patients with intra-abdominal malignancy-related CAP, CPN is a safe and effective procedure which can provide long-lasting significant relief of background pain and BTcP. As part of a multimodal approach, CPN should be considered as an earlier option for pain management in these patients. Springer Healthcare 2021-09-21 2021-12 /pmc/articles/PMC8586091/ /pubmed/34546553 http://dx.doi.org/10.1007/s40122-021-00317-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research
Neuwersch-Sommeregger, Stefan
Köstenberger, Markus
Stettner, Haro
Pipam, Wofgang
Breschan, Christian
Feigl, Georg
Likar, Rudolf
Egger, Markus
CT-Guided Coeliac Plexus Neurolysis in Patients with Intra-Abdominal Malignancy: A Retrospective Evaluation of 52 Palliative In-Patients
title CT-Guided Coeliac Plexus Neurolysis in Patients with Intra-Abdominal Malignancy: A Retrospective Evaluation of 52 Palliative In-Patients
title_full CT-Guided Coeliac Plexus Neurolysis in Patients with Intra-Abdominal Malignancy: A Retrospective Evaluation of 52 Palliative In-Patients
title_fullStr CT-Guided Coeliac Plexus Neurolysis in Patients with Intra-Abdominal Malignancy: A Retrospective Evaluation of 52 Palliative In-Patients
title_full_unstemmed CT-Guided Coeliac Plexus Neurolysis in Patients with Intra-Abdominal Malignancy: A Retrospective Evaluation of 52 Palliative In-Patients
title_short CT-Guided Coeliac Plexus Neurolysis in Patients with Intra-Abdominal Malignancy: A Retrospective Evaluation of 52 Palliative In-Patients
title_sort ct-guided coeliac plexus neurolysis in patients with intra-abdominal malignancy: a retrospective evaluation of 52 palliative in-patients
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586091/
https://www.ncbi.nlm.nih.gov/pubmed/34546553
http://dx.doi.org/10.1007/s40122-021-00317-1
work_keys_str_mv AT neuwerschsommereggerstefan ctguidedcoeliacplexusneurolysisinpatientswithintraabdominalmalignancyaretrospectiveevaluationof52palliativeinpatients
AT kostenbergermarkus ctguidedcoeliacplexusneurolysisinpatientswithintraabdominalmalignancyaretrospectiveevaluationof52palliativeinpatients
AT stettnerharo ctguidedcoeliacplexusneurolysisinpatientswithintraabdominalmalignancyaretrospectiveevaluationof52palliativeinpatients
AT pipamwofgang ctguidedcoeliacplexusneurolysisinpatientswithintraabdominalmalignancyaretrospectiveevaluationof52palliativeinpatients
AT breschanchristian ctguidedcoeliacplexusneurolysisinpatientswithintraabdominalmalignancyaretrospectiveevaluationof52palliativeinpatients
AT feiglgeorg ctguidedcoeliacplexusneurolysisinpatientswithintraabdominalmalignancyaretrospectiveevaluationof52palliativeinpatients
AT likarrudolf ctguidedcoeliacplexusneurolysisinpatientswithintraabdominalmalignancyaretrospectiveevaluationof52palliativeinpatients
AT eggermarkus ctguidedcoeliacplexusneurolysisinpatientswithintraabdominalmalignancyaretrospectiveevaluationof52palliativeinpatients